INTEGRATED BIOPHARMA INC - FORM 10-K - EX-23.1 - EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - September 2, 2021

Attached files

file filename
EX-31.2 - EXHIBIT 31.2 CERTIFICATION OF CFO - INTEGRATED BIOPHARMA INCex_262156.htm
EX-21 - EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT - INTEGRATED BIOPHARMA INCex_262159.htm
EX-32.2 - EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC - INTEGRATED BIOPHARMA INCex_262158.htm
EX-32.1 - EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC - INTEGRATED BIOPHARMA INCex_262157.htm
EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF CO-CEOS - INTEGRATED BIOPHARMA INCex_262155.htm
10-K - FORM 10-K - INTEGRATED BIOPHARMA INCinbp20210630_10k.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We hereby consent to the incorporation by reference in the Registration Statements of Integrated BioPharma, Inc. on Form S-8 (File Nos. 333-229069, 333-37509, 333-87456 and 333-87458) and Form S-3 (File Nos. 333-144155 and 333-149855) of our report dated September 2, 2021, with respect to our audits of the consolidated financial statements as of June 30, 2021 and 2020, and for each of the years in the two year period ended June 30, 2021, which was included in the Company’s Annual Report on Form 10-K filed on September 2, 2021.

 

/s/ Friedman LLP

East Hanover, New Jersey

September 2, 2021

 

Stock widget

Investing forum

INTEGRATED BIOPHARMA INC Reports